Early Breast Cancer Clinical Trial
Official title:
A Phase III, Randomized, Open-Label, Multicenter Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Patients With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer
This is a Phase III, global, randomized, open-label, multicenter, study evaluating the efficacy and safety of adjuvant giredestrant compared with endocrine therapy of physician's choice in participants with medium- and high-risk Stage I-III histologically confirmed estrogen receptor (ER)-positive and human epidermal growth factor receptor 2 (HER2)-negative early breast cancer. In addition, an open-label exploratory substudy will explore the safety and efficacy of giredestrant in combination with abemaciclib in a subset of the primary study population.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT04538833 -
GM1 in the Treatment of Neurotoxicity Induced by Albumin-bound Paclitaxel
|
Phase 2 | |
| Completed |
NCT04436744 -
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer)
|
Phase 2 | |
| Completed |
NCT02187744 -
A Study Of PF-05280014 Or Trastuzumab Plus Taxotere® And Carboplatin In HER2 Positive Breast Cancer In The Neoadjuvant Setting (REFLECTIONS B327-04)
|
Phase 3 | |
| Terminated |
NCT01155063 -
Evaluating The Safety Of Exemestane Following 2-3 Years Of Adjuvant Tamoxifen Therapy In Postmenopausal Early Breast Cancer Patients
|
N/A | |
| Recruiting |
NCT03949634 -
Cardiac Safety and Efficacy for Early-stage Breast Cancer Patients Treated With Pegylated Liposomal Doxorubicin（PLD)
|
Phase 3 | |
| Active, not recruiting |
NCT05730647 -
Prospective Observational Study of Adjuvant Hormone Treatment in Estrogen-receptor Positive Premenopausal Early Breast Cancer Patients
|
||
| Terminated |
NCT01919229 -
A Pharmacodynamics Pre-surgical Study of LEE011 in Early Breast Cancer Patients (MONALEESA-1)
|
Phase 2 | |
| Active, not recruiting |
NCT04293393 -
Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients
|
Phase 2 | |
| Completed |
NCT00713141 -
Evaluation of Brain Function Before and After Standard Chemotherapy for Early Breast Cancer
|
N/A | |
| Recruiting |
NCT06341894 -
Efficacy and Safety of Dalpiciclib With Endocrine Therapy as Adjuvant Treatment in HR+/ HER2- Early Breast Cancer
|
Phase 2 | |
| Not yet recruiting |
NCT06404736 -
QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Early High-Risk TNBC Breast Cancer
|
Phase 2 | |
| Not yet recruiting |
NCT06404463 -
QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Early High-Risk ER+/HER2- Breast Cancer
|
Phase 2 | |
| Not yet recruiting |
NCT06435104 -
Aromatherapy in the Treatment of Early Breast Cancer
|
Phase 2 | |
| Recruiting |
NCT03520894 -
Radiotherapy in Preoperative Setting With CyberKnife for Breast Cancer
|
N/A | |
| Completed |
NCT03786198 -
Activity Program During Aromatase Inhibitor Therapy
|
N/A | |
| Completed |
NCT01613352 -
Feasibility of Ambulatory Surgery for Early Breast Cancer
|
N/A | |
| Completed |
NCT02738970 -
A Dose-Finding Study of Pertuzumab (Perjeta) in Combination With Trastuzumab (Herceptin) in Healthy Male Participants and Women With Early Breast Cancer (EBC)
|
Phase 1 | |
| Recruiting |
NCT01792726 -
A Comparison of Intra-operative Radiotherapy Boost With External Beam Radiotherapy Boost in Early Breast Cancer.
|
N/A | |
| Completed |
NCT00323479 -
Arthralgia During Anastrozole Therapy for Breast Cancer
|
Phase 4 | |
| Completed |
NCT03493854 -
A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer
|
Phase 3 |